TY - JOUR
T1 - The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus
T2 - A randomized controlled trial
AU - Gary, Tiffany L.
AU - Batts-Turner, Marian
AU - Yeh, Hsin Chieh
AU - Hill-Briggs, Felicia
AU - Bone, Lee R.
AU - Wang, Nae Yuh
AU - Levine, David M.
AU - Powe, Neil R.
AU - Saudek, Christopher D.
AU - Hill, Martha N.
AU - Mcguire, Maura
AU - Brancati, Frederick Louis
PY - 2009/10/26
Y1 - 2009/10/26
N2 - Background: Although African American adults bear a disproportionate burden from diabetes mellitus (DM), few randomized controlled trials have tested culturally appropriate interventions to improve DM care. Methods: We randomly assigned 542 African Americans with type 2 DM enrolled in an urban managed care organization to either an intensive or minimal intervention group. The intensive intervention group consisted of all components of the minimal intervention plus individualized, culturally tailored care provided by a nurse case manager( NCM)and a community health worker (CHW), using evidence-basedclinical algorithmswithfeedbacktoprimary care providers (eg, physicians, nurse practitioners, or physician assistants). The minimal intervention consisted of mailingsandtelephone calls every6monthsto remind participants about preventive screenings. Dataondiabetic control were collected at baseline and at 24 months by blind observers; data emergency department (ER) visits and hospitalizations were assessed using administrative data. Results: At baseline, participants had a mean age of 58 years, 73% were women, and 50% were living in poverty. At 24 months, compared with the minimal intervention group, those in the intensive intervention group were 23% less likely to have ER visits (rate difference [RD], -14.5; adjusted rate ratio [RR], 0.77; 95% confidence interval [CI], 0.59-1.00). In on-treatment analyses, the rate reduction was strongest for patients who received the most NCMandCHWvisits (RD, -31.0; adjusted RR, 0.66; 95% CI, 0.43-1.00; rate reduction ↓ 34%). Conclusion: These data suggest that a culturally tailored intervention conducted by an NCM/CHW team reduced ER visits in urban African Americans with type 2 DM. Trial Registration: clinicaltrials.gov Identifier: NCT00022750.
AB - Background: Although African American adults bear a disproportionate burden from diabetes mellitus (DM), few randomized controlled trials have tested culturally appropriate interventions to improve DM care. Methods: We randomly assigned 542 African Americans with type 2 DM enrolled in an urban managed care organization to either an intensive or minimal intervention group. The intensive intervention group consisted of all components of the minimal intervention plus individualized, culturally tailored care provided by a nurse case manager( NCM)and a community health worker (CHW), using evidence-basedclinical algorithmswithfeedbacktoprimary care providers (eg, physicians, nurse practitioners, or physician assistants). The minimal intervention consisted of mailingsandtelephone calls every6monthsto remind participants about preventive screenings. Dataondiabetic control were collected at baseline and at 24 months by blind observers; data emergency department (ER) visits and hospitalizations were assessed using administrative data. Results: At baseline, participants had a mean age of 58 years, 73% were women, and 50% were living in poverty. At 24 months, compared with the minimal intervention group, those in the intensive intervention group were 23% less likely to have ER visits (rate difference [RD], -14.5; adjusted rate ratio [RR], 0.77; 95% confidence interval [CI], 0.59-1.00). In on-treatment analyses, the rate reduction was strongest for patients who received the most NCMandCHWvisits (RD, -31.0; adjusted RR, 0.66; 95% CI, 0.43-1.00; rate reduction ↓ 34%). Conclusion: These data suggest that a culturally tailored intervention conducted by an NCM/CHW team reduced ER visits in urban African Americans with type 2 DM. Trial Registration: clinicaltrials.gov Identifier: NCT00022750.
UR - http://www.scopus.com/inward/record.url?scp=70350517944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350517944&partnerID=8YFLogxK
U2 - 10.1001/archinternmed.2009.338
DO - 10.1001/archinternmed.2009.338
M3 - Article
C2 - 19858437
AN - SCOPUS:70350517944
SN - 0003-9926
VL - 169
SP - 1788
EP - 1794
JO - Archives of internal medicine
JF - Archives of internal medicine
IS - 19
ER -